Literature DB >> 26929288

Intraoperatively Testing the Anastomotic Integrity of Esophagojejunostomy Using Methylene Blue.

S Celik1, N Almalı2, A Aras1, Ö Yılmaz1, R Kızıltan1.   

Abstract

BACKGROUND: Intraoperative testing of gastrointestinal anastomosis effectively ensures anastomotic integrity. This study investigated whether the routine use of methylene blue intraoperatively identified leaks to reduce the postoperative proportion of clinical leaks.
METHODS: This study retrospectively analyzed consecutive total gastrectomies performed from January 2007 to December 2014 in a university hospital setting by a general surgical group that exclusively used the methylene blue test. All surgeries were performed for gastric or junctional cancers (n = 198). All reconstructions (Roux-en Y esophagojejunostomy) were performed using a stapler. The methylene blue test was used in 108 cases (group 1) via a nasojejunal tube. No test was performed for the other 90 cases (group 2). Intraoperative leakage rate, postoperative clinical leakage rate, length of hospitalization, and mortality rate were the outcome measures.
RESULTS: The intraoperative leakage rate was 7.4% in group 1. The postoperative clinical leakage rate was 8.6%. The postoperative clinical leakage rate was 3.7% in group 1 and 14.4% in group 2 (p = 0.007). There were no postoperative clinical leaks when an intraoperative leak led to concomitant intraoperative repair. The median length of hospital stay was 6 days in group 1 and 8 days in group 2 (p < 0.001). One death occurred in each group. No test-related complications were observed.
CONCLUSION: The methylene blue test for esophagojejunostomy is a safe and reliable method for the assessment of anastomosis integrity, especially in cases with difficult esophagojejunostomic construction.

Entities:  

Keywords:  Methylene blue test; anastomosis integrity; esophagojejunostomy

Mesh:

Substances:

Year:  2016        PMID: 26929288     DOI: 10.1177/1457496916630652

Source DB:  PubMed          Journal:  Scand J Surg        ISSN: 1457-4969            Impact factor:   2.360


  6 in total

Review 1.  Evaluating the safety of oral methylene blue during swallowing assessment: a systematic review.

Authors:  Bina Tariq; Sorina R Simon; Walmari Pilz; Andra Maxim; Bernd Kremer; Laura W J Baijens
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-02       Impact factor: 2.503

2.  How to examine anastomotic integrity intraoperatively in totally laparoscopic radical gastrectomy? Methylene blue testing prevents technical defect-related anastomotic leaks.

Authors:  Chun Deng; Yang Liu; Zhen-Yu Zhang; Heng-Duo Qi; Zhi Guo; Xu Zhao; Xiao-Jun Li
Journal:  World J Gastrointest Surg       Date:  2022-04-27

3.  Factors associated with complication after gastrectomy for gastric or esophagogastric cancer compared among surgical purpose, surgical extent, and patient age: Retrospective study from a high volume center in Thailand.

Authors:  Thammawat Parakonthun; Bhurithat Sirisut; Chawisa Nampoolsuksan; Gritin Gonggetyai; Jirawat Swangsri; Asada Methasate
Journal:  Ann Med Surg (Lond)       Date:  2022-06-05

4.  The Birmingham experience of high-pressure methylene blue dye test during primary and revisional bariatric surgery: A retrospective cohort study.

Authors:  G C Kirby; C A W Macano; S M Nyasavajjala; M Sahloul; R Nijjar; M Daskalakis; M Richardson; R Singhal
Journal:  Ann Med Surg (Lond)       Date:  2017-09-28

5.  The problem of colorectal anastomosis safety.

Authors:  Marius Kryzauskas; Eligijus Poskus; Audrius Dulskas; Augustinas Bausys; Matas Jakubauskas; Ugne Imbrasaite; Gabija Makunaite; Justas Kuliavas; Rimantas Bausys; Eugenijus Stratilatovas; Kestutis Strupas; Tomas Poskus
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

6.  Better Safe than Sorry: Prevention of Esophagojejunostomy Leak by Intraoperative Methylene Blue Test in Advanced Gastric Cancer.

Authors:  K Sędłak; Karol Rawicz-Pruszyński; R Mlak; J Mielko; K Gęca; W P Polkowski
Journal:  J Gastrointest Surg       Date:  2021-02-09       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.